Nouri Neamati - Search Results

Year	Number of Results
2001	1
2002	9
2003	3
2004	11
2005	9
2006	18
2007	12
2008	19
2009	16
2010	9
2011	13
2012	14
2013	20
2014	11
2015	5
2016	4
2017	7
2018	14
2019	11
2020	15
2021	6
2022	10
2023	3

1

Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.

Ha H, Debnath B, Neamati N. Ha H, et al. Among authors: neamati n. Theranostics. 2017 Apr 7;7(6):1543-1588. doi: 10.7150/thno.15625. eCollection 2017. Theranostics. 2017. PMID: 28529637 Free PMC article. Review.

2

Role of the ERO1-PDI interaction in oxidative protein folding and disease.

Shergalis AG, Hu S, Bankhead A 3rd, Neamati N. Shergalis AG, et al. Among authors: neamati n. Pharmacol Ther. 2020 Jun;210:107525. doi: 10.1016/j.pharmthera.2020.107525. Epub 2020 Mar 20. Pharmacol Ther. 2020. PMID: 32201313 Free PMC article. Review.

3

Current Challenges and Opportunities in Treating Glioblastoma.

Shergalis A, Bankhead A 3rd, Luesakul U, Muangsin N, Neamati N. Shergalis A, et al. Among authors: neamati n. Pharmacol Rev. 2018 Jul;70(3):412-445. doi: 10.1124/pr.117.014944. Pharmacol Rev. 2018. PMID: 29669750 Free PMC article.

4

Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?

Xu Y, Xue D, Bankhead A 3rd, Neamati N. Xu Y, et al. Among authors: neamati n. J Med Chem. 2020 Dec 10;63(23):14276-14307. doi: 10.1021/acs.jmedchem.0c01013. Epub 2020 Oct 26. J Med Chem. 2020. PMID: 33103432 Free PMC article. Review.

5

Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer.

Madak JT, Bankhead A 3rd, Cuthbertson CR, Showalter HD, Neamati N. Madak JT, et al. Among authors: neamati n. Pharmacol Ther. 2019 Mar;195:111-131. doi: 10.1016/j.pharmthera.2018.10.012. Epub 2018 Oct 19. Pharmacol Ther. 2019. PMID: 30347213 Review.

6

The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress-Mediated Apoptosis in Pancreatic Cancer.

Samanta S, Yang S, Debnath B, Xue D, Kuang Y, Ramkumar K, Lee AS, Ljungman M, Neamati N. Samanta S, et al. Among authors: neamati n. Cancer Res. 2021 Apr 1;81(7):1883-1895. doi: 10.1158/0008-5472.CAN-20-1540. Epub 2021 Feb 2. Cancer Res. 2021. PMID: 33531374 Free PMC article.

7

Advances Toward COVID-19 Therapies Special Issue.

Neamati N. Neamati N. J Med Chem. 2022 Feb 24;65(4):2713-2715. doi: 10.1021/acs.jmedchem.2c00178. Epub 2022 Feb 9. J Med Chem. 2022. PMID: 35138859 Free PMC article. No abstract available.

8

Why All the Fury over Furin?

Osman EEA, Rehemtulla A, Neamati N. Osman EEA, et al. Among authors: neamati n. J Med Chem. 2022 Feb 24;65(4):2747-2784. doi: 10.1021/acs.jmedchem.1c00518. Epub 2021 Aug 2. J Med Chem. 2022. PMID: 34340303 Free PMC article. Review.

9

Simplifying Submission Requirements for the Journal of Medicinal Chemistry.

Lindsley CW, Barrow J, Chibale K, Bolognesi ML, Conway S, Denny W, Ding K, Laufer S, Lai L, Liu H, Neamati N, Suzuki T, Meanwell N, Young W. Lindsley CW, et al. Among authors: neamati n. J Med Chem. 2021 Jun 24;64(12):7877-7878. doi: 10.1021/acs.jmedchem.1c00528. Epub 2021 Jun 15. J Med Chem. 2021. PMID: 34128667 No abstract available.

10

Metal-dependent inhibition of HIV-1 integrase.

Neamati N, Lin Z, Karki RG, Orr A, Cowansage K, Strumberg D, Pais GC, Voigt JH, Nicklaus MC, Winslow HE, Zhao H, Turpin JA, Yi J, Skalka AM, Burke TR Jr, Pommier Y. Neamati N, et al. J Med Chem. 2002 Dec 19;45(26):5661-70. doi: 10.1021/jm0201417. J Med Chem. 2002. PMID: 12477350

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results